Research on the improving function of endothelial progenitor cells in diabetes
10.3969/j.issn.1006-0111.201906065
- VernacularTitle:改善糖尿病内皮祖细胞功能的研究进展
- Author:
Jingxue LIU
1
;
Jin HUANG
2
Author Information
1. Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437 China.
2. Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437 China.john70550@163.com
- Keywords:
diabetes;
endothelial progenitor cells (EPC);
oxidative stress;
inflammation
- From:
Journal of Pharmaceutical Practice
2020;38(1):18-21
- CountryChina
- Language:Chinese
-
Abstract:
Endothelial progenitor cells (EPC) are stem cells derived from bone marrow and peripheral blood, which could proliferate and differentiate into endothelial cells and participate in repair after tube injury. Studies have shown that the improving function of diabetic EPC could prevent and reduce the occurrence of diabetic complications. The research progress in improving the function of EPC in recent years and the improvement of function in the development of diabetes were reviewed in order to provide new ideas for the treatment of diabetes.
